Retrospective Comparison of Azithromycin, Clarithromycin, and Erythromycin for the Treatment of Foals with Rhodococcus equi Pneumonia
Authors:
- 1 July 2004
- journal article
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 18 (4) , 568-573
Abstract
The objective of this retrospective study was to compare the efficacy of azithromycin-rifampin, clarithromycin-rifampin, and erythromycin-rifampin for the treatment of pneumonia caused by Rhodococcus equi in foals. Eighty-one foals with naturally acquired pneumonia caused by R equi were included in the study. Information on age, sex, breed, physical examination findings, laboratory testing, and thoracic radiography was abstracted from each medical record. Foals were divided in 3 groups based on the antimicrobial agent selected for therapy. Short-term (discharge from the hospital) and long-term (apparently healthy as a yearling) success rates, days of hospitalization, days with fever, days with tachypnea, and percentage of radiographic improvement were compared among groups. Foals treated with clarithromycin-rifampin had significantly (P= .02) higher odds of overall short-term (odds ratio [OR] = 12.2) and long-term (OR = 20.6) treatment success and significantly fewer days with fever than foals treated with erythromycin-rifampin. Foals treated with clarithromycin-rifampin had a significantly (P= .03) higher percentage of radiographic improvement and a tendency (P= .06) toward higher odds of overall short-term (OR = 8.1) and long-term (OR = 11.8) treatment success compared to foals treated with azithromycin-rifampin. Among foals with severe radiographic lesions, the success rates of foals treated with clarithromycin-rifampin both short-term (88%) and long-term (83%) were significantly (P = .02) higher than that of foals treated with azithromycin-rifampin (0%). For each treatment group, the only reported adverse effect was diarrhea that was mild and self-limiting in most cases. The combination clarithromycin-rifampin is superior to azithromycin-rifampin or erythromycin-rifampin for the treatment of pneumonia caused by R equi in foals in a referral population.Keywords
This publication has 22 references indexed in Scilit:
- In Vitro Susceptibilities ofRhodococcus equiand Other Common Equine Pathogens to Azithromycin, Clarithromycin, and 20 Other AntimicrobialsAntimicrobial Agents and Chemotherapy, 2003
- Pharmacokinetics of azithromycin in foals after i.v. and oral dose and disposition into phagocytesJournal of Veterinary Pharmacology and Therapeutics, 2002
- Pharmacokinetics of azithromycin and concentration in body fluids and bronchoalveolar cells in foalsAmerican Journal of Veterinary Research, 2001
- Randomized, Open‐Label Trial of Azithromycin Plus Ethambutol vs. Clarithromycin Plus Ethambutol as Therapy forMycobacterium aviumComplex Bacteremia in Patients with Human Immunodeficiency Virus InfectionClinical Infectious Diseases, 1998
- Clostridium difficile associated with acute colitis in mares when their foals are treated with erythromycin and rifampicin for Rhodococcus equi pneumoniaEquine Veterinary Journal, 1998
- Azithromycin and Clarithromycin Overview and Comparison With ErythromycinInfection Control & Hospital Epidemiology, 1992
- A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumoniaJournal of Antimicrobial Chemotherapy, 1991
- Use of erythromycin-rifampin combination in treatment of Rhodococcus equi pneumoniaVeterinary Microbiology, 1987
- Rhodococcus equi pneumonia in 48 foals: Response to antimicrobial therapyVeterinary Microbiology, 1987
- Corynebacterium equi: An interhost review with emphasis on the foalComparative Immunology, Microbiology and Infectious Diseases, 1980